Jump Financial’s Maravai LifeSciences MRVI Stock Holding History

Jump Financial’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-37,617	Closed	-$313K	–	1869
2024 Q3	$313K	Sell	37,617 -10,888	-22%	-$94.1K	0.01%	1287
2024 Q2	$347K	Buy	+48,505	New	+$419K	0.01%	1319
2024 Q1	–	Sell	-34,400	Closed	-$225K	–	2149
2023 Q4	$225K	Buy	+34,400	New	+$222K	0.01%	1502
2023 Q1	–	Sell	-45,164	Closed	-$646K	–	1881
2022 Q4	$646K	Buy	+45,164	New	+$711K	0.03%	670
2022 Q2	–	Sell	-128,021	Closed	-$4.51M	–	1865
2022 Q1	$4.51M	Buy	128,021 +61,521	+93%	+$2.06M	0.19%	74
2021 Q4	$2.79M	Buy	66,500 +7,341	+12%	+$297K	0.17%	132
2021 Q3	$2.9M	Sell	59,159 -5,741	-9%	-$280K	0.21%	78
2021 Q2	$2.71M	Buy	+64,900	New	+$2.52M	0.26%	50

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jump Financial's MRVI Position: Q4 2024 in Review

Jump Financial sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 37,617 shares — an estimated $313K sold.

Jump Financial first reported a position in MRVI in Q2 2021 and held it in 8 quarters. The position peaked at $4.51M in Q1 2022. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

Jump Financial reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
Jump Financial sold 37,617 Maravai LifeSciences shares in Q4 2024, an estimated $313K.
Jump Financial first reported a position in Maravai LifeSciences in Q2 2021 and held it in 8 quarters.
Jump Financial's Maravai LifeSciences position peaked at $4.51M in Q1 2022.
185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on Jump Financial's 13F filing for Q4 2024, filed 13 Feb 2025.